Cargando…

Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function

Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox or L1) are the current standard of care for the treatment of iron overload. Although each chelator is capable of promoting some degree of ir...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Jasmine L., Hatef, Azadeh, Imran ul-haq, Muhammad, Nair, Neelima, Unniappan, Suraj, Kizhakkedathu, Jayachandran N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199627/
https://www.ncbi.nlm.nih.gov/pubmed/25329065
http://dx.doi.org/10.1371/journal.pone.0109880
_version_ 1782339943480164352
author Hamilton, Jasmine L.
Hatef, Azadeh
Imran ul-haq, Muhammad
Nair, Neelima
Unniappan, Suraj
Kizhakkedathu, Jayachandran N.
author_facet Hamilton, Jasmine L.
Hatef, Azadeh
Imran ul-haq, Muhammad
Nair, Neelima
Unniappan, Suraj
Kizhakkedathu, Jayachandran N.
author_sort Hamilton, Jasmine L.
collection PubMed
description Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox or L1) are the current standard of care for the treatment of iron overload. Although each chelator is capable of promoting some degree of iron excretion, these chelators are also associated with a wide range of well documented toxicities. However, there is currently very limited data available on their effects in developing embryos. In this study, we took advantage of the rapid development and transparency of the zebrafish embryo, Danio rerio to assess and compare the toxicity of iron chelators. All three iron chelators described above were delivered to zebrafish embryos by direct soaking and their effects on mortality, hatching and developmental morphology were monitored for 96 hpf. To determine whether toxicity was specific to embryos, we examined the effects of chelator exposure via intra peritoneal injection on the cardiac function and gene expression in adult zebrafish. Chelators varied significantly in their effects on embryo mortality, hatching and morphology. While none of the embryos or adults exposed to DFO were negatively affected, ICL -treated embryos and adults differed significantly from controls, and L1 exerted toxic effects in embryos alone. ICL-670 significantly increased the mortality of embryos treated with doses of 0.25 mM or higher and also affected embryo morphology, causing curvature of larvae treated with concentrations above 0.5 mM. ICL-670 exposure (10 µL of 0.1 mM injection) also significantly increased the heart rate and cardiac output of adult zebrafish. While L1 exposure did not cause toxicity in adults, it did cause morphological defects in embryos at 0.5 mM. This study provides first evidence on iron chelator toxicity in early development and will help to guide our approach on better understanding the mechanism of iron chelator toxicity.
format Online
Article
Text
id pubmed-4199627
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41996272014-10-21 Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function Hamilton, Jasmine L. Hatef, Azadeh Imran ul-haq, Muhammad Nair, Neelima Unniappan, Suraj Kizhakkedathu, Jayachandran N. PLoS One Research Article Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox or L1) are the current standard of care for the treatment of iron overload. Although each chelator is capable of promoting some degree of iron excretion, these chelators are also associated with a wide range of well documented toxicities. However, there is currently very limited data available on their effects in developing embryos. In this study, we took advantage of the rapid development and transparency of the zebrafish embryo, Danio rerio to assess and compare the toxicity of iron chelators. All three iron chelators described above were delivered to zebrafish embryos by direct soaking and their effects on mortality, hatching and developmental morphology were monitored for 96 hpf. To determine whether toxicity was specific to embryos, we examined the effects of chelator exposure via intra peritoneal injection on the cardiac function and gene expression in adult zebrafish. Chelators varied significantly in their effects on embryo mortality, hatching and morphology. While none of the embryos or adults exposed to DFO were negatively affected, ICL -treated embryos and adults differed significantly from controls, and L1 exerted toxic effects in embryos alone. ICL-670 significantly increased the mortality of embryos treated with doses of 0.25 mM or higher and also affected embryo morphology, causing curvature of larvae treated with concentrations above 0.5 mM. ICL-670 exposure (10 µL of 0.1 mM injection) also significantly increased the heart rate and cardiac output of adult zebrafish. While L1 exposure did not cause toxicity in adults, it did cause morphological defects in embryos at 0.5 mM. This study provides first evidence on iron chelator toxicity in early development and will help to guide our approach on better understanding the mechanism of iron chelator toxicity. Public Library of Science 2014-10-16 /pmc/articles/PMC4199627/ /pubmed/25329065 http://dx.doi.org/10.1371/journal.pone.0109880 Text en © 2014 Hamilton et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Hamilton, Jasmine L.
Hatef, Azadeh
Imran ul-haq, Muhammad
Nair, Neelima
Unniappan, Suraj
Kizhakkedathu, Jayachandran N.
Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function
title Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function
title_full Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function
title_fullStr Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function
title_full_unstemmed Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function
title_short Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function
title_sort clinically approved iron chelators influence zebrafish mortality, hatching morphology and cardiac function
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199627/
https://www.ncbi.nlm.nih.gov/pubmed/25329065
http://dx.doi.org/10.1371/journal.pone.0109880
work_keys_str_mv AT hamiltonjasminel clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction
AT hatefazadeh clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction
AT imranulhaqmuhammad clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction
AT nairneelima clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction
AT unniappansuraj clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction
AT kizhakkedathujayachandrann clinicallyapprovedironchelatorsinfluencezebrafishmortalityhatchingmorphologyandcardiacfunction